Tarsus Pharmaceuticals, Inc.
TARS · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $94,819 | $224,947 | $71,660 | $171,332 |
| Short-Term Investments | $196,557 | $2,495 | $145,366 | $483 |
| Receivables | $48,059 | $17,714 | $3,582 | $92 |
| Inventory | $2,620 | $3,107 | $0 | $0 |
| Other Curr. Assets | $14,650 | $7,868 | $4,767 | $4,045 |
| Total Curr. Assets | $356,705 | $256,131 | $225,375 | $175,952 |
| Property Plant & Equip (Net) | $2,866 | $3,348 | $1,532 | $1,829 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $8,326 | $3,867 | $0 | $0 |
| Long-Term Investments | $3,000 | $631 | $371 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $6,094 | $1,514 | $585 | $1,126 |
| Total NC Assets | $20,286 | $9,360 | $2,488 | $2,955 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $376,991 | $265,491 | $227,863 | $178,907 |
| Liabilities | – | – | – | – |
| Payables | $27,739 | $17,772 | $5,498 | $2,856 |
| Short-Term Debt | $608 | $398 | $721 | $1,306 |
| Tax Payable | $0 | $0 | $14 | $55 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $52,265 | $18,766 | $9,196 | $7,261 |
| Total Curr. Liab. | $80,612 | $36,936 | $15,429 | $11,478 |
| LT Debt | $71,845 | $29,819 | $19,486 | $585 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $1,748 | $48 | $114 |
| Total NC Liab. | $71,845 | $31,567 | $19,534 | $699 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $608 | $398 | $773 | $1,891 |
| Total Liabilities | $152,457 | $68,503 | $34,963 | $12,177 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $6 | $5 | $5 | $4 |
| Retained Earnings | -$360,210 | -$244,656 | -$108,763 | -$46,672 |
| AOCI | $179 | -$2 | -$74 | $0 |
| Other Equity | $584,559 | $441,641 | $301,732 | $213,398 |
| Total Equity | $224,534 | $196,988 | $192,900 | $166,730 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $376,991 | $265,491 | $227,863 | $178,907 |
| Net Debt | -$22,366 | -$194,730 | -$51,453 | -$169,441 |